Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
Lily E. Adams, Sarah R. Leist, Kenneth H. Dinnon, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112326-112326
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
Christin Schmidt, Barbara S. Schnierle
Pathogens (2023) Vol. 12, Iss. 1, pp. 138-138
Open Access | Times Cited: 37
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 24
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
C. Pierre, Lily E. Adams, Jaclyn S. Higgins, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1011569-e1011569
Open Access | Times Cited: 11
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy
Penny L. Moore, T. Leighton, Julie Ostrowsky, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2101-2112
Open Access | Times Cited: 19
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus
Jimin Lee, Samantha K. Zepeda, Young‐Jun Park, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 12, pp. 1961-1973.e11
Open Access | Times Cited: 18
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
Jimin Lee, Cameron Stewart, Alexandra Schäfer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice
Peter Halfmann, Raj S. Patel, Kathryn Loeffler, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Immunoglobulin replacement products confer in vivo protection against SARS-CoV-2 XBB.1.5 Omicron variant despite poor neutralizing activity
Ofer Zimmerman, Alexa Michelle Altman Doss, Baoling Ying, et al.
JCI Insight (2024)
Open Access | Times Cited: 3
Concurrent Administration of COVID-19 and Influenza Vaccines Enhances Spike-Specific Antibody Responses
Susanna E Barouch, Taras M. Chicz, Ross Blanc, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 4
Open Access | Times Cited: 3
Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
Jacob A. Dillard, Sharon Taft-Benz, Audrey C. Knight, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS-CoV-2, to Induce a Broader Response
Yadira Lobaina, Rong Chen, Edith Suzarte, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 588-588
Open Access | Times Cited: 2
Randomised controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine
Wen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 2
SARS-CoV-2-related bat viruses evade human intrinsic immunity but lack efficient transmission capacity
Mario A. Peña-Hernández, Mia Madel Alfajaro, Renata B. Filler, et al.
Nature Microbiology (2024) Vol. 9, Iss. 8, pp. 2038-2050
Closed Access | Times Cited: 2
Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice
Elif Karaaslan, Teresa E. Sorvillo, Florine E. M. Scholte, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
C. Pierre, Lily E. Adams, Kara Anasti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Understanding Fc function for rational vaccine design against pathogens
Kathryn Bowman, Paulina Kapłonek, Ryan P. McNamara
mBio (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Sarbecovirus disease susceptibility is conserved across viral and host models
Sarah R. Leist, Alexandra Schäfer, Ellen L Risemberg, et al.
Virus Research (2024) Vol. 346, pp. 199399-199399
Open Access | Times Cited: 1
Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques
Xin Tong, Qixin Wang, Wonyeong Jung, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110174-110174
Open Access | Times Cited: 1
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral families
Matthew J. Vukovich, Andrea R. Shiakolas, Jared Lindenberger, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012499-e1012499
Open Access | Times Cited: 1
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice
James Brett Case, Shilpa Sanapala, Carly Dillen, et al.
Cell Host & Microbe (2024)
Open Access | Times Cited: 1
Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV
Naveenchandra Suryadevara, Nurgun Kose, Sandhya Bangaru, et al.
Journal of Clinical Investigation (2024) Vol. 135, Iss. 3
Open Access | Times Cited: 1
Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography
Julie M. Fox, Vicky Roy, Bronwyn M. Gunn, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus
Jimin Lee, Samantha K. Zepeda, Young‐Jun Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
Jimin Lee, Cameron Stewart, Alexandra Schaefer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top